Triple
T1103734
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Leqembi |
E25439
|
entity |
| Predicate | isFirstInClass |
P5008
|
FINISHED |
| Object | first anti-amyloid Alzheimer’s drug with full FDA approval (as of 2023) |
—
|
LITERAL FINISHED |
Provenance (3 batches)
| Stage | Batch ID | Job type | Status |
|---|---|---|---|
| creating | batch_69a49428d4448190b3b36991ceae87ce |
elicitation | completed |
| NER | batch_69a4b9c375848190baec4d534f489616 |
ner | completed |
| PD | batch_69a4b7472c848190b0643872f67084a2 |
pd | completed |
Created at: March 1, 2026, 7:43 p.m.